SE386451B - Forfarande for framstellning av 10beta-metyl-delta9(11)-dea-steroider - Google Patents

Forfarande for framstellning av 10beta-metyl-delta9(11)-dea-steroider

Info

Publication number
SE386451B
SE386451B SE7214662A SE1466272A SE386451B SE 386451 B SE386451 B SE 386451B SE 7214662 A SE7214662 A SE 7214662A SE 1466272 A SE1466272 A SE 1466272A SE 386451 B SE386451 B SE 386451B
Authority
SE
Sweden
Prior art keywords
10beta
delta9
dea
steroids
methyl
Prior art date
Application number
SE7214662A
Other languages
English (en)
Inventor
P Buchschager
A Furst
L Labler
W Meier
J W Scott
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE386451B publication Critical patent/SE386451B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385Saturated compounds containing a keto group being part of a ring
    • C07C49/417Saturated compounds containing a keto group being part of a ring polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/16Benz[e]indenes; Hydrogenated benz[e]indenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7214662A 1971-11-12 1972-11-10 Forfarande for framstellning av 10beta-metyl-delta9(11)-dea-steroider SE386451B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1651671A CH586174A5 (sv) 1971-11-12 1971-11-12

Publications (1)

Publication Number Publication Date
SE386451B true SE386451B (sv) 1976-08-09

Family

ID=4418045

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7214662A SE386451B (sv) 1971-11-12 1972-11-10 Forfarande for framstellning av 10beta-metyl-delta9(11)-dea-steroider
SE7512007A SE7512007L (sv) 1971-11-12 1975-10-27 10beta-metyl-delta?729?72(?721?721?72)-dea-sterpoder for anvendning sasom mellanprodukter vid framstellning av verdefulla steroider

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7512007A SE7512007L (sv) 1971-11-12 1975-10-27 10beta-metyl-delta?729?72(?721?721?72)-dea-sterpoder for anvendning sasom mellanprodukter vid framstellning av verdefulla steroider

Country Status (12)

Country Link
JP (1) JPS4857964A (sv)
AT (1) AT323908B (sv)
AU (1) AU465178B2 (sv)
BE (1) BE791184A (sv)
CH (1) CH586174A5 (sv)
DE (1) DE2250426A1 (sv)
FR (1) FR2160178A5 (sv)
GB (1) GB1374850A (sv)
IL (1) IL40433A (sv)
NL (1) NL7213810A (sv)
SE (2) SE386451B (sv)
ZA (1) ZA726400B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2500440A1 (fr) * 1981-02-23 1982-08-27 Roussel Uclaf Nouveaux medicaments derives de la 3-hydroxy dodecahydro benz (e) inden-7-one disubstituee en position 6, produits derives de la 3-hydroxy dodecahydro benz (e) inden-7-one disubstituee en position 6, et leur procede de preparation ainsi que des produits intermediaires

Also Published As

Publication number Publication date
IL40433A (en) 1976-05-31
IL40433A0 (en) 1972-11-28
AT323908B (de) 1975-08-11
FR2160178A5 (sv) 1973-06-22
ZA726400B (en) 1973-07-25
JPS4857964A (sv) 1973-08-14
DE2250426A1 (de) 1973-05-17
GB1374850A (en) 1974-11-20
BE791184A (fr) 1973-05-10
CH586174A5 (sv) 1977-03-31
NL7213810A (sv) 1973-05-15
AU465178B2 (en) 1975-09-18
AU4695472A (en) 1974-03-28
SE7512007L (sv) 1975-10-27

Similar Documents

Publication Publication Date Title
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE411755B (sv) Forfarande for framstellning av n-substituerade 1-aminometylindaner
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE393615B (sv) Forfarande for framstellning av 6-metyl-8 beta-ureidometyl-ergolener
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE391332B (sv) Forfarande for framstellning av en fenyletanolamin
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
SE398123B (sv) Forfarande for framstellning av metoximetylestern av hetacillin
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE387948B (sv) Forfarande for framstellning av tiofen
SE407061B (sv) Forfarande for framstellning av bensylpyrimidiner
NO136975C (no) Fremgangsm}te til fremstilling av nitrilotriacetonitril
SE392724B (sv) Forfarande for framstellning av 7-aminocefalosporansyra
SE394279B (sv) Forfarande for framstellning av kinoxalin-di-n-oxider